Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001013762-14-001381
Filing Date
2014-11-19
Accepted
2014-11-19 15:31:58
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 INTELLICELL BIOSCIENCES, INC. FORM 10-Q f10q0914_intellicell.htm 10-Q 769290
2 EXHIBIT 31.1 f10q0914ex31i_intellicell.htm EX-31.1 12598
3 EXHIBIT 31.2 f10q0914ex31ii_intellicell.htm EX-31.2 12614
4 EXHIBIT 32.1 f10q0914ex32i_intellicell.htm EX-32.1 5429
5 EXHIBIT 32.2 f10q0914ex32ii_intellicell.htm EX-32.2 5626
  Complete submission text file 0001013762-14-001381.txt   6206079

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE svfc-20140930.xml EX-101.INS 1073992
7 XBRL SCHEMA FILE svfc-20140930.xsd EX-101.SCH 64100
8 XBRL CALCULATION FILE svfc-20140930_cal.xml EX-101.CAL 58470
9 XBRL DEFINITION FILE svfc-20140930_def.xml EX-101.DEF 138505
10 XBRL LABEL FILE svfc-20140930_lab.xml EX-101.LAB 369675
11 XBRL PRESENTATION FILE svfc-20140930_pre.xml EX-101.PRE 242652
Mailing Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021
Business Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021 (212) 249-3050
Intellicell Biosciences, Inc. (Filer) CIK: 0001125280 (see all company filings)

EIN.: 911966948 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54729 | Film No.: 141234927
SIC: 2836 Biological Products, (No Diagnostic Substances)